Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Boston Scientific to acquire American Medical Systems' urology portfolio

March 5, 2015

EMA's CHMP backs approval of Jinarc for rare kidney disease

March 2, 2015

InSys in-licenses novel therapy for chronic pelvic pain syndrome

Feb. 26, 2015

Shanghai Institute Materia Medica discloses new alpha1A-adrenoreceptor antagonists

Feb. 16, 2015

ViveBio signs licensing agreement with Renovar for urine-based biomarkers for kidney disease

Feb. 13, 2015

Aurinia plans pilot biomarker study of voclosporin in lupus nephritis

Feb. 11, 2015

Tenapanor achieves primary endpoint in phase IIb hyperphosphatemia trial

Feb. 4, 2015

Xiapex approved in E.U. for Peyronie's disease

Feb. 2, 2015

CF-602 shows promise for sexual dysfunction in preclinical studies

Jan. 28, 2015

FDA awards orphan drug status to Sparsentan for focal segmental glomerulosclerosis

Jan. 13, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...